Foreign Product Alert
2007-48
April 13, 2007
For immediate release
Health Canada is advising consumers not to use the following product listed in the table below due to concerns about possible side-effects. More info
V.MAX, Rhino Max (Rhino V Max)
| Date of alert |
April 13, 2007 |
| Source of Alert |
United States Food and Drug Administration |
| Product Names |
V.MAX, Rhino Max (Rhino V Max) |
| Manufacturer / Place of Origin |
V.MAX - Barodon SF Inc., Los Angeles, CA USA
Rhino Max (Rhino V Max) - Cosmos Trading Inc., Los Angeles, CA USA |
| Products Description |
V.MAX and Rhino Max (Rhino V Max) are marketed as dietary supplements in the US.
V.MAX: packaged with an outer box containing three smaller boxes each containing five capsules.
Rhino Max (Rhino V Max): packaged in boxes containing five or 15 tablets.
|
| Reason for Warning |
The United States Food and Drug Administration found V.MAX and Rhino Max (Rhino V Max) to contain undeclared amounts of aminotadalafil, an analogue of tadalafil, used to treat erectile dysfunction. Aminotadalafil is not intended to be used in self-care, and should only be taken under the guidance of a health professional. |
| Possible Side Effects |
Aminotadalafil may have side effects including headache and flushing, and more serious effects such as severe hypotension (low blood pressure), and may potentially interact with nitrate-containing medications.
Individuals with diabetes, high blood pressure, high cholesterol, or heart disease who may be using nitrate-containing drugs may be at the greatest risk of adverse reactions with the use of V.MAX and Rhino Max (Rhino V Max), since these products are not labelled with the appropriate warnings of potential risks and contraindications for aminotadalafil. |
-30-
Media Inquiries:
Health Canada
(613) 957-2983
This product is not authorized for sale in Canada and has not been found in the Canadian marketplace. However, it is possible this product could be purchased by Canadians travelling abroad or has been brought into Canada through personal importation by travellers or purchased over the Internet.
Canadians who have this product are advised not to use it, and should consult with a health care professional if they have concerns about their health related to the use of this product.
Drugs and natural health products that are authorized for sale in Canada will have either an eight-digit Drug Identification Number (DIN), a Natural Product Number (NPN) or a Homeopathic Medicine Number (DIN-HM) on the label. These numbers indicate that the products have been assessed by Health Canada for safety, effectiveness and quality.
Health Canada advises Canadians to contact the Health Products and Food Branch Inspectorate at 1-800-267-9675 if they find the product listed in the table in the Canadian marketplace.
For more information about the information contained in this advisory, please contact Health Canada's public inquiries line at (613) 957-2991 or toll-free at 1-866-225-0709.
As of the date of this posting, no adverse reactions suspected to be associated with the use of this product have been reported in Canada.
|
